Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Ialuril vs dimethyl sulfoxide in women with interstitial cystitis / painful bladder syndrome
2010-021556-25Phase 3Completed
- Sponsor
- IBSA Group
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Ialuril in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by IBSA Group. Primary endpoint: Pain intensity (VAS 0–100). Started Nov 2010; status: completed.
02
Drugs
Ialuril
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2010-021556-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021556-25.